For 30 years, Jeremy Levin served as a physician, biotech venture capitalist, biotech entrepreneur, chair of the board of the Biotechnology Innovation Organization, and executive leader of both large and small biopharmaceutical companies. Today he is chair and CEO of Ovid Therapeutics, Inc., a public company developing novel medicines to treat epilepsies and seizure-related disorders.
Key Takeaways
-
Jeremy Levin, Scrip Awards Lifetime Achievement winner, emphasizes the need for the biopharma industry to rebuild trust with patients.
Born in South Africa, Levin moved during childhood with his family to the UK and, after gaining degrees from both...